Future perspectives for mTOR inhibitors in renal cell cancer treatment. [electronic resource]
Producer: 20151120Description: 801-17 p. digitalISSN:- 1744-8301
- Animals
- Antineoplastic Agents -- pharmacology
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Autophagy -- drug effects
- Carcinoma, Renal Cell -- drug therapy
- Clinical Trials as Topic
- Humans
- Kidney Neoplasms -- drug therapy
- Neoplastic Stem Cells -- drug effects
- Protein Kinase Inhibitors -- pharmacology
- TOR Serine-Threonine Kinases -- antagonists & inhibitors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.